Treating them with the PARP inhibitor talazoparib revealed that the molecular subtype with a high copy number is sensitive to the PARP inhibitor.175 The mTOR pathway is essential for gastric cancer (GC), but the mTOR inhibitor everolimus is not universally effective in treating gastric cancer. This evidence concerns the gene MTOR and gastric cancer.